News
Novo Nordisk anticipates that the next round of medications targeted for price setting negotiations with the federal government will include its wildly popular diabetes drug Ozempic. During a ...
Hosted on MSN4mon
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiationsThe Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's (NVO) blockbuster GLP-1s.
March 14 (Reuters) - All drug manufacturers, including Novo Nordisk (NOVOb.CO), opens new tab and Teva Pharmaceuticals (TEVA.TA), opens new tab, whose medicines are part of the second round of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback